openPR Logo
Press release

Focus day announced for SMi’s 11th annual RNA Therapeutics conference 2020

10-03-2019 05:21 PM CET | Health & Medicine

Press release from: SMI

RNA Therapeutics conference 2020

RNA Therapeutics conference 2020

SMi Reports: RNA Therapeutics conference and focus day to return on February 2020, in London

SMi Group is proud to announce the return of RNA Therapeutics conference for its 11th year, commencing on 18th – 20th February 2020 in London, UK. The field of RNA therapeutics is currently undergoing major growth, and the potential for using RNA drugs for personalised medicines and immunotherapy, as well as to address genetic, infectious and chronic diseases will ensure the continued development of RNA therapeutics for years to come.

RNA Therapeutics Conference 2020 is chaired by BioNTech’s Vice President RNA Formulation and Drug Delivery, Heinrich Haas. The aim of the event is to bring together industry experts from leading RNA therapeutics companies to discuss the challenges for clinical translation of RNA-based therapeutics, with an emphasis on recent advances in delivery technologies, and present an overview of the applications of RNA-based drugs for modulation of gene and protein expression, and genome editing.

Key profiles presenting:

• Shalini Andersson, Chief Scientist New Therapeutic Modalities, AstraZeneca
• Christian Plank, CTO, Ethris
• Steve Pascolo, Founder and CEO, Miescher Pharma
• Kirsty Wydenbach, Deputy Unit Manager, Clinical Trials Unit, MhRA
• Steven Powell, CEO, eTheRNA
• Simon Newman, CSO, Nanogenics
• Christiane Niederlaender, Director, AMBR Consulting and Formerly, Quality Assessor, Biologicals, MhRA
• Klaus Giese, CEO, Pantherna Therapeutics
• David Blakey, CSO, MiNA Therapeutics
• Jeffrey Ulmer, Head Preclinical R&D, GSK

For those interested in attending, there is an early bird saving of £400 for registrations made by 31st October available at

This year, the event has a new addition to the agenda, where a pre-conference Focus Day - ‘Oligonucleotide Delivery Systems’ is scheduled on 18th February 2020. The focus day will discuss the innovations and challenges in oligonucleotide delivery systems and will be chaired by Shalini Andersson, Chief Scientist New Therapeutic Modalities from AstraZeneca.

Featured Speakers Include:

• Enrico Mastrobattista, Professor of Pharmaceutical Biotechnology & Delivery, University Utrecht
• Pete Lutwyche, CTO, Genevant Sciences
• David Evans, CSO, Sirnaomics, Inc
• Antonin De Fougerolles, CEO, Evox Therapeutics
• Heinrich Haas, VP RNA Formulation and Drug Delivery, BioNTech
• Steve Pascolo, Founder and CEO, Miescher Pharma Gmbh

Highlights of the event:

• Discover Ethris’ mRNA therapeutic approach to pulmonary disease
• Gain insight into the opportunities and challenges in developing microRNA-based drugs from Sanofi
• Explore the progress in small activating RNAs as a novel therapeutic class of oligonucleotides from MiNA Therapeutics
• Understand how to break down the immune barrier in cancer through systemic mRNA immunisation from eTheRNA
• Learn from GSK’s discovery and development of self-amplifying mRNA vaccines

View the full agenda and speaker line-up online:

RNA Therapeutics
Conference:19th – 20th February 2020
Focus Day: 18th February 2020
London, UK

Proudly sponsored by:
ChemGenes | Thermo Fisher Scientific

--- ENDS –
Contact Information:
For media enquiries contact Alia Malick on +44 (0)20 7827 6168
For all delegate enquiries, contact Hakam Panum on +44 (0)20 7827 6128

45 Curlew Street

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Focus day announced for SMi’s 11th annual RNA Therapeutics conference 2020 here

News-ID: 1842776 • Views: 464

More Releases from SMI

Senior US officials from fuel policy teams and combat wings to present at Milita …
SMi reports: Senior US officials will be presenting at the 21st Annual Military Airlift Air-to-Air Refuelling conference in Seville, this December Air-to-air refuelling remains a key mission multiplier, utilised extensively in Operation Inherent Resolve to extend flight times for bombing runs against ISIS. As the US Air Force explores the greater utilisation of commercial refuellers for CONUS operations to free military assets for combat and international deployment there is a critical
Senior experts to discuss Naval Mine Countermeasures at Unmanned Maritime System …
The challenge posed by potential adversary mining capabilities is real and growing. For all navies, there is only one way to completely “Take the sailor out of the minefield,” and that is to leverage unmanned technologies to hunt and destroy mines from a distance.* By embracing technological advancements in unmanned systems, such as UUVs and USVs, they could sweep large portions of the sea while minimizing the risk to sailors. For
Military Robotics and Autonomous Systems 2020 announced as a Virtual Event
SMi Reports: Due to the ongoing challenges surrounding COVID-19, Military Robotics and Autonomous Systems in September will now run as a virtual event. With the continued uncertainty surrounding large gatherings in the UK, SMi Group have made the decision to turn the 3rd annual Military Robotics and Autonomous Systems Conference on the 2nd-3rd September 2020 into a fully interactive virtual meeting. All attendance by military and government will be free of charge
04-07-2020 | Health & Medicine
Associates of Cape Cod Webinar on Recombinant Chromogenic Assay as Alternate Met …
SMi Reports: Associates of Cape Cod to host an online webinar taking place on Wednesday 29th April 2020. SMi Group is delighted to announce a free webinar led by Associates of Cape Cods on 'Recombinant Chromogenic Assay as Alternate Methods for Bacterial Endotoxins Test (BET)' taking place on 29th April 2020 at 10am EDT (3pm BST - UK time). The webinar will aim to review the global perspective on the use

All 5 Releases

More Releases for RNA

Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand. Browse 156 Market Data Tables and 112 Figures spread through 175
DNA/RNA Extraction Equipment Market: Competitive Dynamics & Global Outlook 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global DNA/RNA Extraction Equipment market. Robotic liquid handling technology in automated DNA extraction systems can streamline the tasks involved in extracting DNA from a sample, such as serial dilution and cherry picking. Systems typically also include functions such as shaking, temperature control, and PCR protocols. DNA extraction is used in many types of biological research including molecular
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year. Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved
Automated DNA/RNA Isolation System Market Overview Till 2018-2023
Future Market Reports on Global Automated DNA/RNA Isolation System 2018 Research Report presents a professional and complete analysis of on the current Industry situation. The Global report includes Automated DNA/RNA Isolation System Revenue, market Share, industry volume, Trends, Growth aspects. It analyses the important factors of the based on present industry situations, demands, business strategies utilized by Automated DNA/RNA Isolation System market players and the future prospects from various angles
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018! Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion. One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and